SNCA and Parkinson disease: This study shows the interaction between glucocerebrosidase mutation and α-synuclein aggregation, as well as the fact that the rs12411216 SNP is a causal variable that might be used as a de novo biomarker for mild PD cognitive impairment prognosis [136].